Antimicrobial stewardship programs: methods of operation and suggested outcomes

References

• Spellberg B, Blaser M, Guidos RJ et al. Combating antimicrobial resistance: policy recommendations to save lives. Clin. Infect. Dis.52(Suppl. 5), S397–S428 (2011).
   PubMed Web of Science ®Google Scholar
• Dellit TH, Owens RC, McGowan JE Jr et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis.44(2), 159–177 (2007).
   PubMed Web of Science ®Google Scholar
• Hoffman JM, Doloresco F, Vermeulen LC et al. Projecting future drug expenditures – 2010. Am. J. Health Syst. Pharm.67(11), 919–928 (2010).
   PubMedGoogle Scholar
• Drew RH, White R, MacDougall C, Hermsen ED, Owens RC Jr. Insights from the Society of infectious diseases pharmacists on antimicrobial stewardship guidelines from the Infectious diseases Society of America and the Society for healthcare epidemiology of America. Pharmacotherapy29(5), 593–607 (2009).
   PubMed Web of Science ®Google Scholar
• McGuire JM, Wolfe RN, Ziegler DW. Vancomycin, a new antibiotic. II. In vitro antibacterial studies. Antibiot. Ann.3, 612–618 (1955).
   PubMedGoogle Scholar
• Griffith RS, Peck FB Jr. Vancomycin, a new antibiotic. III. Preliminary clinical and laboratory studies. Antibiot. Ann.3, 619–622 (1955).
   PubMedGoogle Scholar
• Pakyz A, Powell JP, Harpe SE, Johnson C, Edmond M, Polk RE. Diversity of antimicrobial use and resistance in 42 hospitals in the United States. Pharmacotherapy28(7), 906–912 (2008).
   PubMedGoogle Scholar
• Pakyz AL, MacDougall C, Oinonen M, Polk RE. Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch. Intern. Med.168(20), 2254–2260 (2008).
   PubMedGoogle Scholar
• Huovinen P, Seppala H, Kataja J, Klaukka T. The relationship between erythromycin consumption and resistance in Finland. Finnish study group for antimicrobial resistance. Ciba. Found Symp.207, 36–41, Discussion 41–36 (1997).
   PubMedGoogle Scholar
• McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev. Infect. Dis.5(6), 1033–1048 (1983).
   PubMedGoogle Scholar
• Courcol RJ, Pinkas M, Martin GR. A seven year survey of antibiotic susceptibility and its relationship with usage. J. Antimicrob. Chemother.23(3), 441–451 (1989).
   PubMed Web of Science ®Google Scholar
• Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among Gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA289(7), 885–888 (2003).
   PubMed Web of Science ®Google Scholar
• Paterson DL, Ko WC, Von Gottberg A et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin. Infect. Dis.39(1), 31–37 (2004).
   PubMed Web of Science ®Google Scholar
• Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin. Infect. Dis.39(1), 11–17 (2004).
   PubMed Web of Science ®Google Scholar
• MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin. Microbiol. Rev.18(4), 638–656, Table of Contents (2005).
   PubMed Web of Science ®Google Scholar
• Paladino JA. Economics of antibiotic use policies. Pharmacotherapy24(2 Pt 12), S232–S238 (2004).
   Google Scholar
• Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin. Infect. Dis.36(11), 1433–1437 (2003).
   PubMed Web of Science ®Google Scholar
• Stosor V, Peterson LR, Postelnick M, Noskin GA. Enterococcus faecium bacteremia: does vancomycin resistance make a difference? Arch. Intern. Med.158(5), 522–527 (1998).
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Carmeli Y. Studies of bloodstream infection outcomes: reading between the lines. Infect. Cont. Hosp. Epidemiol.24(12), 884–886 (2003).
   PubMedGoogle Scholar
• Roberts RR, Hota B, Ahmad I et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin. Infect. Dis.49(8), 1175–1184 (2009).
   PubMed Web of Science ®Google Scholar
• Kollef MH. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis.31(Suppl. 4), S131–S138 (2000).
   Google Scholar
• Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest115(2), 462–474 (1999).
   PubMed Web of Science ®Google Scholar
• Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med.34(6), 1589–1596 (2006).
   PubMed Web of Science ®Google Scholar
• Shehab N, Patel PR, Srinivasan A, Budnitz DS. Emergency department visits for antibiotic-associated adverse events. Clin. Infect. Dis.47(6), 735–743 (2008).
   PubMed Web of Science ®Google Scholar
• Decker WW, Campbell RL, Manivannan V et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester epidemiology project. J. Allergy Clin. Immunol.122(6), 1161–1165 (2008).
   PubMed Web of Science ®Google Scholar
• Chalasani N, Fontana RJ, Bonkovsky HL et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology135(6), 1924–1934, 1934.e1–1934.e4 (2008).
   PubMed Web of Science ®Google Scholar
• Bartlett JG, Perl TM. The new Clostridium difficile – what does it mean? N. Engl. J. Med.353(23), 2503–2505 (2005).
   PubMed Web of Science ®Google Scholar
• Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin. Infect. Dis.46(Suppl. 1), S32–S42 (2008).
   PubMed Web of Science ®Google Scholar
• Duquaine S, Kitchell E, Tate T, Tannen RC, Wickremasinghe IM. Central nervous system toxicity associated with ertapenem use. Ann. Pharmacother.45(1), e6 (2011).
   Google Scholar
• Bellon A, Perez-Garcia G, Coverdale JH, Chacko RC. Seizures associated with levofloxacin: case presentation and literature review. Eur. J. Clin. Pharmacol.65(10), 959–962 (2009).
   PubMedGoogle Scholar
• Scheetz MH, McKoy JM, Parada JP et al. Systematic review of piperacillin-induced neutropenia. Drug Saf.30(4), 295–306 (2007).
   PubMed Web of Science ®Google Scholar
• Gerber L, Wing EJ. Life-threatening neutropenia secondary to piperacillin/tazobactam therapy. Clin. Infect. Dis.21(4), 1047–1048 (1995).
   PubMed Web of Science ®Google Scholar
• Polk RE, Fox C, Mahoney A, Letcavage J, MacDougall C. Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy. Clin. Infect. Dis.44(5), 664–670 (2007).
   PubMed Web of Science ®Google Scholar
• Pakyz AL, Gurgle HE, Ibrahim OM, Oinonen MJ, Polk RE. Trends in antibacterial use in hospitalized pediatric patients in United States academic health centers. Infect. Cont. Hosp. Epidemiol.30(6), 600–603 (2009).
   PubMed Web of Science ®Google Scholar
• Ernst EJ, Klepser ME, Bosso JA et al. Recommendations for training and certification for pharmacists practicing, mentoring, and educating in infectious diseases pharmacotherapy. Pharmacotherapy29(4), 482–488 (2009).
   PubMedGoogle Scholar
• Cooke J, Alexander K, Charani E et al. Antimicrobial stewardship: an evidence-based, antimicrobial self-assessment toolkit (ASAT) for acute hospitals. J. Antimicrob. Chemother.65(12), 2669–2673 (2010).
   PubMedGoogle Scholar
• Pope SD, Dellit TH, Owens RC, Hooton TM. Results of survey on implementation of infectious diseases Society of America and society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect. Cont. Hosp. Epidemiol.30(1), 97–98 (2009).
   PubMed Web of Science ®Google Scholar
• Johannsson B, Beekmann SE, Srinivasan A, Hersh AL, Laxminarayan R, Polgreen PM. Improving antimicrobial stewardship: the evolution of programmatic strategies and barriers. Infect. Cont. Hosp. Epidemiol.32(4), 367–374 (2011).
   PubMedGoogle Scholar
• Gross R, Morgan AS, Kinky DE, Weiner M, Gibson GA, Fishman NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin. Infect. Dis.33(3), 289–295 (2001).
   PubMed Web of Science ®Google Scholar
• Septimus EJ, Owens RC Jr. Need and potential of antimicrobial stewardship in community hospitals. Clin. Infect. Dis.53(Suppl. 1), S8–S14 (2011).
   PubMedGoogle Scholar
• LaRocco A Jr. Concurrent antibiotic review programs – a role for infectious diseases specialists at small community hospitals. Clin. Infect. Dis.37(5), 742–743 (2003).
   PubMedGoogle Scholar
• Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev.4, CD003543 (2005).
   PubMedGoogle Scholar
• Samore MH, Bateman K, Alder SC et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA294(18), 2305–2314 (2005).
   PubMed Web of Science ®Google Scholar
• Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect. Cont. Hosp. Epidemiol.24(9), 699–706 (2003).
   PubMed Web of Science ®Google Scholar
• Lautenbach E, LaRosa LA, Marr AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin. Infect. Dis.36(4), 440–446 (2003).
   PubMed Web of Science ®Google Scholar
• Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J. Antimicrob. Chemother.53(5), 853–859 (2004).
   PubMed Web of Science ®Google Scholar
• Rahal JJ, Urban C, Horn D et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. JAMA280(14), 1233–1237 (1998).
   PubMed Web of Science ®Google Scholar
• Andersson DI. The biological cost of mutational antibiotic resistance: any practical conclusions? Curr. Opin. Microbiol.9(5), 461–465 (2006).
   PubMed Web of Science ®Google Scholar
• Sjolund M, Tano E, Blaser MJ, Andersson DI, Engstrand L. Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg. Infect. Dis.11(9), 1389–1393 (2005).
   PubMed Web of Science ®Google Scholar
• Defife R, Scheetz MH, Feinglass JM, Postelnick MJ, Scarsi KK. Effect of differences in MIC values on clinical outcomes in patients with bloodstream infections caused by Gram-negative organisms treated with levofloxacin. Antimicrob. Agents Chemother.53(3), 1074–1079 (2009).
   PubMed Web of Science ®Google Scholar
• Reddy P, Scheetz MH, Postelnick M, Sutton S, Zembower T, Bolon M. Critical interventions of an antimicrobial stewardship program using computer-based surveillance. Presented at: Society for Healthcare Epidemiology of America, 19th Annual Scientific Meeting. San Diego, CA, USA, 19–22 March, 2009.
   Google Scholar
• Scheetz MH, Bolon MK, Postelnick M, Noskin GA, Lee TA. Cost–effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis. J. Antimicrob. Chemother.63(4), 816–825 (2009).
   PubMed Web of Science ®Google Scholar
• Phillips KA, Shlipak MG, Coxson P et al. Health and economic benefits of increased β-blocker use following myocardial infarction. JAMA284(21), 2748–2754 (2000).
   PubMed Web of Science ®Google Scholar
• Littenberg B, Garber AM, Sox HC Jr. Screening for hypertension. Ann. Intern. Med.112(3), 192–202 (1990).
   PubMed Web of Science ®Google Scholar
• Graham JD, Thompson KM, Goldie SJ, Segui-Gomez M, Weinstein MC. The cost-effectiveness of air bags by seating position. JAMA278(17), 1418–1425 (1997).
   PubMed Web of Science ®Google Scholar
• Warren DK, Hill HA, Merz LR et al. Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients. Crit. Care Med.32(12), 2450–2456 (2004).
   PubMed Web of Science ®Google Scholar
• Merz LR, Warren DK, Kollef MH, Fraser VJ. Effects of an antibiotic cycling program on antibiotic prescribing practices in an intensive care unit. Antimicrob. Agents Chemother.48(8), 2861–2865 (2004).
   PubMed Web of Science ®Google Scholar
• Harbarth S, Nobre V, Pittet D. Does antibiotic selection impact patient outcome? Clin. Infect. Dis.44(1), 87–93 (2007).
   PubMedGoogle Scholar
• Kanwar M, Brar N, Khatib R, Fakih MG. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule. Chest131(6), 1865–1869 (2007).
   PubMed Web of Science ®Google Scholar
• Metersky ML, Sweeney TA, Getzow MB, Siddiqui F, Nsa W, Bratzler DW. Antibiotic timing and diagnostic uncertainty in Medicare patients with pneumonia: is it reasonable to expect all patients to receive antibiotics within 4 hours? Chest130(1), 16–21 (2006).
   PubMed Web of Science ®Google Scholar
• Welker JA, Huston M, McCue JD. Antibiotic timing and errors in diagnosing pneumonia. Arch. Intern. Med.168(4), 351–356 (2008).
   PubMedGoogle Scholar
• Drew RH, Kawamoto K, Adams MB. Information technology for optimizing the management of infectious diseases. Am. J. Health Syst. Pharm.63(10), 957–965 (2006).
   PubMedGoogle Scholar
• Pestotnik SL. Expert clinical decision support systems to enhance antimicrobial stewardship programs: insights from the society of infectious diseases pharmacists. Pharmacotherapy25(8), 1116–1125 (2005).
   PubMed Web of Science ®Google Scholar
• Richards MJ, Robertson MB, Dartnell JG et al. Impact of a web-based antimicrobial approval system on broad-spectrum cephalosporin use at a teaching hospital. Med. J. Aust.178(8), 386–390 (2003).
   PubMed Web of Science ®Google Scholar
• Patel JA, Scheetz MH, Esterly JS et al. Successful piperacillin-tazobactam de-escalation program as an antimicrobial stewardship initiative. Presented at: Society for Healthcare Epidemiology of America, 20th Annual Scientific Meeting. Dallas, TX, USA, 1–4 April, 2011.
   Google Scholar
• Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin. Infect. Dis.37(1), 59–64 (2003).
   PubMed Web of Science ®Google Scholar
• McGregor JC, Weekes E, Forrest GN et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J. Am. Med. Inform. Assoc.13(4), 378–384 (2006).
   PubMed Web of Science ®Google Scholar
• Fraser GL, Stogsdill P, Dickens JD Jr, Wennberg DE, Smith RP Jr, Prato BS. Antibiotic optimization. An evaluation of patient safety and economic outcomes. Arch. Intern. Med.157(15), 1689–1694 (1997).
   PubMedGoogle Scholar
• Gums JG, Yancey RW Jr, Hamilton CA, Kubilis PS. A randomized, prospective study measuring outcomes after antibiotic therapy intervention by a multidisciplinary consult team. Pharmacotherapy19(12), 1369–1377 (1999).
   PubMed Web of Science ®Google Scholar
• Solomon DH, Van Houten L, Glynn RJ et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch. Intern. Med.161(15), 1897–1902 (2001).
   PubMed Web of Science ®Google Scholar
• Camins BC, King MD, Wells JB et al. Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial. Infect. Cont. Hosp. Epidemiol.30(10), 931–938 (2009).
   PubMedGoogle Scholar
• Carling PC, Fung T, Coldiron JS. Parenteral antibiotic use in acute-care hospitals: a standardized analysis of fourteen institutions. Clin. Infect. Dis.29(5), 1189–1196 (1999).
   PubMed Web of Science ®Google Scholar